HLS Therapeutics (HLS) AGM 2024 summary

Opening remarks and agenda

• Meeting opened with a welcome and instructions for virtual participation, including Q&A and voting procedures.

• Forward-looking statements disclaimer was read, highlighting risks and uncertainties.

• Officers and director nominees were introduced, and the agenda was outlined: financial statements, election of directors, and auditor reappointment.

Board and executive committee updates

• Eight nominees for director positions were present and introduced, with their election as a key agenda item.

Overview of voting outcomes

• Voting was conducted online, with instructions for both shareholders and proxy holders.

• All matters put to a ballot, including director elections and auditor reappointment, passed with requisite shareholder support.

• Voting results will be filed on SEDAR+ and disclosed in a press release.